Jomaa Pharma GmbH Report issue

For profit Phase 2
Founded: Hamburg Germany (1998)
Status: Defunct (2016)

Organization Overview

First Clinical Trial
2008
NCT01464125
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Malaria (Phase 2)

Malaria, Falciparum (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 4